Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell

C Weiss1, G Wulf, A D Ho

  • 1Department of Internal Medicine V, University of Heidelberg, F.R.G.

Immunology Letters
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021
Same author

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Bone marrow transplantation·2017
Same author

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC cancer·2017
Same author

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis·2017
Same author

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.

Bone marrow transplantation·2017
Same journal

The dendritic cell identity crisis: why conflicting classifications demand a consensus framework?

Immunology letters·2026
Same journal

The malignancy within: what cancer teaches us about human bonds.

Immunology letters·2026
Same journal

Progranulin enhances complement component 5a-primed neutrophil activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Immunology letters·2026
Same journal

The newly identified role of TRIM72, an E3 ligase, in NINJ1-mediated plasma membrane rupture: focus on its anti-inflammatory function.

Immunology letters·2026
Same journal

The subsets of circulating follicular helper T cells play an important role in the pathogenesis of Autoimmune thyroid diseases.

Immunology letters·2026
Same journal

Could bradykinin pathway inhibition change the course of severe hantavirus disease?

Immunology letters·2026
See all related articles

Splenectomy impacts immune cells, causing a temporary drop in soluble CD4 and CD8 levels. However, soluble CD8 levels remain suppressed long-term, suggesting reduced suppressor cell activity after spleen removal.

Area of Science:

  • Immunology
  • Surgical Oncology

Background:

  • Splenectomy, the surgical removal of the spleen, can influence immune function.
  • Understanding the impact on lymphocyte subpopulations is crucial for patient management.

Purpose of the Study:

  • To investigate the effects of splenectomy on lymphocyte subpopulations.
  • To analyze changes in serum concentrations of soluble CD4 and CD8 antigens post-splenectomy.

Main Methods:

  • Monitored serum concentrations of soluble suppressor/cytotoxic (sCD8) and soluble helper/inducer (sCD4) antigens in 11 splenectomized patients.
  • Performed conventional immunophenotyping using monoclonal antibodies to CD4 and CD8.

Main Results:

  • Observed an early postoperative drop in both sCD8 and sCD4 levels within the first week.

Related Experiment Videos

  • Noted that while sCD4 levels returned to preoperative values, sCD8 concentrations remained suppressed up to 3 months post-splenectomy.
  • Found significantly lower sCD8 levels at the nadir and 3 months post-splenectomy compared to preoperative values.

    • Conclusions:

    • Splenectomy leads to transient alterations in peripheral blood lymphocyte subsets.
    • Sustained suppression of sCD8 levels suggests a long-term reduction in suppressor/cytotoxic cell activity following splenectomy.